| Description |
xii, 124 p. : ill. (some col.). |
| Bibliography |
Includes bibliographical references. |
| Contents |
Introduction -- New clinical trial designs. Phase 0 trials -- Adaptive trial designs -- Targeting multiple pathways with multiple drugs -- Preclinical model systems -- Molecular imaging. Current and developing methods -- Challenges of molecular imaging -- Screening for predictive markers. The challenges of clinical validation -- Bioimaging predictive markers -- Clinical translation -- Panel discussion -- Costs of clinical trials. Regulatory costs -- Patient accrual -- Global outsourcing -- Time is money -- Public-private collaborations -- Regulatory issues. Regulatory barriers to innovation -- Patient advocacy perspective -- Regulation of in vitro diagnostics -- Regulatory issues in improving cancer clinical trials -- Reports from the case study discussion groups. Adaptive trial design -- Phase 0 trials -- Imaging -- Use of proteomics/genomics to assign therapy in lung cancer -- Use of genetics/genomics to assign therapy. |
| Form |
Also available on the World Wide Web. |
| Reproduction |
Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. |
| Subject |
Cancer -- Treatment -- United States.
|
|
Clinical trials.
|
| Genre/Form |
Electronic books.
|
| Added Author |
Patlak, Margie.
|
|
Nass, Sharyl J.
|
|
National Cancer Policy Forum (U.S.)
|
|
Institute of Medicine (U.S.)
|
|
ProQuest (Firm)
|
| ISBN |
9780309116688 |
|
0309116686 |
|
